Sageworth Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-579
Closed -$533K 157
2026
Q1
$533K Buy
579
+31
+6% +$31.4K 0.02% 110
2025
Q4
$589K Sell
548
-1,933
-78% -$1.85M 0.03% 86
2025
Q3
$1.89M Buy
+2,481
New +$1.85M 0.09% 65
2024
Q3
Sell
-276
Closed -$250K 118
2024
Q2
$250K Buy
+276
New +$221K 0.02% 99
2023
Q2
Sell
-43
Closed -$14.8K 269
2023
Q1
$14.8K Sell
43
-116
-73% -$39.1K ﹤0.01% 239
2022
Q4
$58K Sell
159
-3
-2% -$1.06K ﹤0.01% 120
2022
Q3
$52K Sell
162
-678
-81% -$215K ﹤0.01% 111
2022
Q2
$272K Buy
+840
New +$252K 0.02% 68
2021
Q3
Sell
-50
Closed -$11K 869
2021
Q2
$11K Hold
50
﹤0.01% 567
2021
Q1
$9K Sell
50
-144
-74% -$28.2K ﹤0.01% 249
2020
Q4
$33K Buy
194
+144
+288% +$21.5K ﹤0.01% 139
2020
Q3
$7K Sell
50
-1
-2% -$155 ﹤0.01% 149
2020
Q2
$8K Buy
51
+1
+2% +$153 ﹤0.01% 139
2020
Q1
$7K Hold
50
﹤0.01% 132
2019
Q4
$7K Buy
+50
New +$5.8K ﹤0.01% 162

Other funds holding LLY

Sageworth Trust's LLY Position: Q2 2026 in Review

Sageworth Trust sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 579 shares — an estimated $533K sold.

Sageworth Trust first reported a position in LLY in Q4 2019 and held it in 15 quarters. The position peaked at $1.89M in Q3 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sageworth Trust reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Sageworth Trust sold 579 Eli Lilly shares in Q2 2026, an estimated $533K.
  • Sageworth Trust first reported a position in Eli Lilly in Q4 2019 and held it in 15 quarters.
  • Sageworth Trust's Eli Lilly position peaked at $1.89M in Q3 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sageworth Trust's 13F filing for Q2 2026, filed 28 Jul 2026.